61 – 70 of 190
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer : a nationwide, observational follow up study in Sweden
(
- Contribution to journal › Article
-
Mark
Short article : Influence of regulatory NLRC5 variants on colorectal cancer survival and 5-fluorouracil-based chemotherapy
(
- Contribution to journal › Article
-
Mark
Chemotherapy-induced peripheral neuropathy : Evidence from genome-wide association studies and replication within multiple myeloma patients
(
- Contribution to journal › Article
-
Mark
Multiple myeloma : family history and mortality in second primary cancers
(
- Contribution to journal › Letter
-
Mark
Whole genome sequencing reveals DICER1 as a candidate predisposing gene in familial Hodgkin lymphoma
(
- Contribution to journal › Letter
-
Mark
Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma
(
- Contribution to journal › Article
-
Mark
Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance : a genome-wide genetic interaction study
(
- Contribution to journal › Article
-
Mark
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
(
- Contribution to journal › Article
-
Mark
Familial risks of second primary cancers and mortality in ovarian cancer patients
(
- Contribution to journal › Article
-
Mark
Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family
(
- Contribution to journal › Article